These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22426014)

  • 41. Motivational reserve: motivation-related occupational abilities and risk of mild cognitive impairment and Alzheimer disease.
    Forstmeier S; Maercker A; Maier W; van den Bussche H; Riedel-Heller S; Kaduszkiewicz H; Pentzek M; Weyerer S; Bickel H; Tebarth F; Luppa M; Wollny A; Wiese B; Wagner M;
    Psychol Aging; 2012 Jun; 27(2):353-63. PubMed ID: 21875213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. One-year Outcome of Shanghai Mild Cognitive Impairment Cohort Study.
    Zhou B; Zhao Q; Kojima S; Ding D; Higashide S; Nagai Y; Guo Q; Kagimura T; Fukushima M; Hong Z
    Curr Alzheimer Res; 2019; 16(2):156-165. PubMed ID: 30484408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroanatomical correlates of awareness of illness in patients with amnestic mild cognitive impairment who will or will not convert to Alzheimer's disease.
    Spalletta G; Piras F; Piras F; Sancesario G; Iorio M; Fratangeli C; Cacciari C; Caltagirone C; Orfei MD
    Cortex; 2014 Dec; 61():183-95. PubMed ID: 25481475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
    Hall A; Muñoz-Ruiz M; Mattila J; Koikkalainen J; Tsolaki M; Mecocci P; Kloszewska I; Vellas B; Lovestone S; Visser PJ; Lötjonen J; Soininen H; ; ;
    J Alzheimers Dis; 2015; 44(1):79-92. PubMed ID: 25201784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.
    Tapiola T; Pennanen C; Tapiola M; Tervo S; Kivipelto M; Hänninen T; Pihlajamäki M; Laakso MP; Hallikainen M; Hämäläinen A; Vanhanen M; Helkala EL; Vanninen R; Nissinen A; Rossi R; Frisoni GB; Soininen H
    Neurobiol Aging; 2008 Jan; 29(1):31-8. PubMed ID: 17097769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.
    Lebedev AV; Westman E; Van Westen GJ; Kramberger MG; Lundervold A; Aarsland D; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Simmons A;
    Neuroimage Clin; 2014; 6():115-25. PubMed ID: 25379423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-term delayed recall of auditory verbal learning test provides equivalent value to long-term delayed recall in predicting MCI clinical outcomes: A longitudinal follow-up study.
    Xu Y; Chen K; Zhao Q; Li F; Guo Q
    Appl Neuropsychol Adult; 2020; 27(1):73-81. PubMed ID: 30470140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Responsiveness of magnetic resonance imaging and neuropsychological assessment in memory clinic patients.
    Schmand B; Rienstra A; Tamminga H; Richard E; van Gool WA; Caan MW; Majoie CB
    J Alzheimers Dis; 2014; 40(2):409-18. PubMed ID: 24473187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population.
    Prins ND; van der Flier WM; Brashear HR; Knol DL; van de Pol LA; Barkhof F; Scheltens P
    J Alzheimers Dis; 2013; 36(1):79-85. PubMed ID: 23563246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project).
    Sánchez-Benavides G; Peña-Casanova J; Casals-Coll M; Gramunt N; Molinuevo JL; Gómez-Ansón B; Aguilar M; Robles A; Antúnez C; Martínez-Parra C; Frank-García A; Fernández-Martínez M; Blesa R;
    J Alzheimers Dis; 2014; 41(3):887-901. PubMed ID: 24718100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cortical thickness analysis to detect progressive mild cognitive impairment: a reference to Alzheimer's disease.
    Julkunen V; Niskanen E; Muehlboeck S; Pihlajamäki M; Könönen M; Hallikainen M; Kivipelto M; Tervo S; Vanninen R; Evans A; Soininen H
    Dement Geriatr Cogn Disord; 2009; 28(5):404-12. PubMed ID: 19907176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk classification for conversion from mild cognitive impairment to Alzheimer's disease in primary care.
    Qin Y; Tian Y; Han H; Liu L; Ge X; Xue H; Wang T; Zhou L; Liang R; Yu H;
    Psychiatry Res; 2019 Aug; 278():19-26. PubMed ID: 31132572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment.
    Spulber G; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Lovestone S; Wahlund LO; Westman E;
    J Intern Med; 2013 Apr; 273(4):396-409. PubMed ID: 23278858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropsychological performance and conversion to Alzheimer's disease in early- compared to late-onset amnestic mild cognitive impairment: CREDOS study.
    Ye BS; Seo SW; Lee Y; Kim SY; Choi SH; Lee YM; Kim DH; Han HJ; Na DL; Kim EJ
    Dement Geriatr Cogn Disord; 2012; 34(3-4):156-66. PubMed ID: 23037957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer's disease.
    Sohn D; Shpanskaya K; Lucas JE; Petrella JR; Saykin AJ; Tanzi RE; Samatova NF; Doraiswamy PM
    Sci Rep; 2018 May; 8(1):7490. PubMed ID: 29748598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The association between "Brain-Age Score" (BAS) and traditional neuropsychological screening tools in Alzheimer's disease.
    Beheshti I; Maikusa N; Matsuda H
    Brain Behav; 2018 Aug; 8(8):e01020. PubMed ID: 29931756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing predictors of conversion to Alzheimer's disease using the disease state index.
    Muñoz-Ruiz MÁ; Hall A; Mattila J; Koikkalainen J; Herukka SK; Vanninen R; Liu Y; Lötjönen J; Soininen H;
    Neurodegener Dis; 2014; 13(2-3):200-2. PubMed ID: 23969422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease.
    Huang M; Yang W; Feng Q; Chen W;
    Sci Rep; 2017 Jan; 7():39880. PubMed ID: 28079104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of the PredictAD software tool to predict progression in patients with mild cognitive impairment.
    Simonsen AH; Mattila J; Hejl AM; Frederiksen KS; Herukka SK; Hallikainen M; van Gils M; Lötjönen J; Soininen H; Waldemar G
    Dement Geriatr Cogn Disord; 2012; 34(5-6):344-50. PubMed ID: 23222123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.